SM
STAB
Sabby Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-69,103
| Closed | -$22K | – | 112 |
|
|
2022
Q1 | $22K | Sell |
69,103
-315,494
| -82% | -$100K | ﹤0.01% | 81 |
|
|
2021
Q4 | $885K | Buy |
384,597
+18,137
| +5% | +$41.7K | 0.13% | 50 |
|
|
2021
Q3 | $847K | Sell |
366,460
-33,620
| -8% | -$77.7K | 0.11% | 50 |
|
|
2021
Q2 | $2.19M | Sell |
400,080
-78,861
| -16% | -$431K | 0.31% | 27 |
|
|
2021
Q1 | $2.51M | Buy |
+478,941
| New | +$2.51M | 0.49% | 18 |
|
|
2015
Q1 | – | Sell |
-377,156
| Closed | -$108 | – | 190 |
|
|
2014
Q4 | $108 | Sell |
377,156
-503,900
| -57% | -$144 | ﹤0.01% | 96 |
|
|
2014
Q3 | $404 | Buy |
881,056
+574,891
| +188% | +$264 | 0.02% | 79 |
|
|
2014
Q2 | $147K | Sell |
306,165
-1,519,993
| -83% | -$730K | 0.01% | 93 |
|
|
2014
Q1 | $1.24M | Buy |
+1,826,158
| New | +$1.24M | 0.07% | 45 |
|